GlassScriptPhysician profile
Rajesh Patel
NPI 1225022965
$53,712.59
in general payments reported to CMS, 2019-2025
21 companies · $97.18 in 2025
The $97.18 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,039 · 2020: $2,839 · 2021: $21K · 2022: $17K · 2023: $7,258 · 2024: $315 · 2025: $97.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,150 · Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,150.00 |
| Food and Beverage | $520.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $48,347.72 | 2019-2023 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $3,727.89 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Actelion Pharmaceuticals US, INC. | $312.27 | 2019-2022 | |
| Pulmonx Corporation | $182.47 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.83 | 2019-2022 | |
| Genzyme Corporation | $133.46 | 2019-2022 | |
| Inspire Medical Systems, INC. | $132.67 | 2023-2024 | Inspire |
| Mallinckrodt Hospital Products INC. | $99.99 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $95.98 | 2020-2025 | Dupixent |
| Mylan Specialty L.P. | $91.48 | 2019-2024 | Yupelri |
| Lilly USA, LLC | $74.12 | 2019 | |
| Genentech USA, INC. | $66.64 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.39 | 2020-2022 | |
| United Therapeutics Corporation | $54.79 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $35.24 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $32.48 | 2019-2020 | |
| Philips North America LLC | $30.19 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $27.08 | 2019-2021 | |
| Insmed, INC. | $24.87 | 2019 | |
| Merck Sharp & Dohme LLC | $24.11 | 2019 | |
| Shire North American Group INC | $22.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.